Calibrate Stock

Calibrate is a digital metabolic health business that is changing the way the world treats weight.

Sign up today and learn more about Calibrate Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Calibrate Stock

Calibrate is a digital metabolic health business that provides a virtual program for weight loss. It is creating a new category by improving metabolic health to drive long-term, sustainable weight loss with a program designed by world leaders in obesity and nutrition science. Calibrate combines FDA-approved metabolic medication with a holistic curriculum and 1:1 virtual coaching sessions that drive lasting behavior change. The company was founded in 2020 and is headquartered in New York.

Funding History

January 2021$2.1M
January 2021$3.0M
January 2021$15.1M
July 2021$76.1M


Founder, CEO

Isabelle Kenyon

Chief Medical Officer

Kim Boyd

Chief Marketing Officer

Katy Marshall


Claudia Huapaya

Board Member

Brian Singerman

Medical Director

Sona Shah

Director, Business Operations

Sintha Rajasingham

Board Member

Emily Melton

Board Member

Kira Wampler

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: